Catalyst Wire Dossier Catalyst Wire Dossier

Cellegesic

nitroglycerin ointment 0.4% · Forest Laboratories
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cellegesic, covering 2016-11-03 to 2016-11-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Determine the Effect of Nitroglycerin Ointment 0.4% (Cellegesic) on the Pain Associated With Chronic Anal Fissures [Phase 3]

See pricing